Global Immuno-Oncology Assay Market Comprehensive Analysis and Forecast 2023 to 2028

Global Immuno-Oncology Assay Market Overview: 2023-2028

Base Year: 2022

Historical Years: 2018-21

Forecast Years: 2023-2028

The Global Immuno-Oncology Assay Market size is valued at around USD 5.77 billion in 2024 and is estimated to grow at a CAGR of around 12.5% during the forecast period, i.e., 2023-28. The Global Immuno-Oncology Assay Market is going through significant growth due to multiple drivers like technological advancements and, of course, increasing healthcare needs. The increase in road accidents throughout the country creates a greater demand for X-rays.

Markntel Advisor’s Global Immuno-Oncology Assay Market Insights report provides the current and forecast market analysis, individual leading companies' market shares, challenges, Global Immuno-Oncology Assay Market drivers, barriers, Global Immuno-Oncology Assay Market Trends, and Key Players in Global Immuno-Oncology Assay Market.

Download a sample copy of the Report: https://www.marknteladvisors.com/query/request-sample/immuno-oncology-assay-market.html

Global Immuno-Oncology Assay Market Dynamics: 2023-2028

Global Immuno-Oncology Assay Market Challenge:

Shortage of Skilled Professionals Hampering the Market Growth– The market players in the Global Immuno-Oncology Assay market have been facing substantial challenges. One of those challenges is a critical shortage of skilled professionals, such as lab technicians and technologists, who possess the advanced laboratory expertise required to advance the field. This scarcity of qualified personnel represents a significant obstacle to the market's growth trajectory. For instance,

In 2022, according to the American Society for Clinical Pathology, the United States and Canada faced a significant lack of medical laboratory workers. There were only about one medical laboratory scientist for every 1,000 people, with a shortage of 20,000 to 25,000 professionals.

This dearth of skilled individuals with the necessary proficiency and experience not only impedes the efficiency of assays but also hampers the data interpretation step required for the assays. Also, as skilled professionals are required across research laboratories as well to carry out research and development processes, this is projected to hamper the development of high-end immunoassay services in the coming years.

Browse Full Report with Detail Analysis – https://www.marknteladvisors.com/research-library/immuno-oncology-assay-market.html

Global Immuno-Oncology Assay Market (2023-30): Segmentation Outlook

The market report has segmented the market into the following categories:

By Product & Services

-Reagents and Antibodies- Market Size & Forecast 2018-2028F, USD Million

-Testing Kits- Market Size & Forecast 2018-2028F, USD Million

-Instruments- Market Size & Forecast 2018-2028F, USD Million

-Consumables & Accessories- Market Size & Forecast 2018-2028F, USD Million

-Software- Market Size & Forecast 2018-2028F, USD Million

By Assay Type

-Checkpoint Inhibitor Assays- Market Size & Forecast 2018-2028F, USD Million

-Cytokine Profiling Assays- Market Size & Forecast 2018-2028F, USD Million

-Protein Biomarker Assays- Market Size & Forecast 2018-2028F, USD Million

-Genomic Sequencing and Mutational Analysis- Market Size & Forecast 2018-2028F, USD Million

-Immune Profiling Assays- Market Size & Forecast 2018-2028F, USD Million

-Tumour Biomarker Assays-  Market Size & Forecast 2018-2028F, USD Million

-Others (Gene Expression Profiling Assays, Multiplex Assays, etc.)- Market Size & Forecast 2018-2028F, USD Million

By Technology

-Polymerase Chain Reaction- Market Size & Forecast 2018-2028F, USD Million

-Immunoassay- Market Size & Forecast 2018-2028F, USD Million

-Next-generation Sequencing- Market Size & Forecast 2018-2028F, USD Million

-In-situ Hybridization- Market Size & Forecast 2018-2028F, USD Million

-Flow Cytometry- Market Size & Forecast 2018-2028F, USD Million

-Others (Mass Spectrometry, Immunohistochemistry (IHC), etc.) - Market Size & Forecast 2018-2028F, USD Million

By Indication

-Lung Cancer- Market Size & Forecast 2018-2028F, USD Million

-Breast Cancer- Market Size & Forecast 2018-2028F, USD Million

-Colorectal Cancer- Market Size & Forecast 2018-2028F, USD Million

-Prostate Cancer- Market Size & Forecast 2018-2028F, USD Million

-Ovarian Cancer- Market Size & Forecast 2018-2028F, USD Million

-Others (Bladder Cancer, Melanoma, etc.)- Market Size & Forecast 2018-2028F, USD Million

By Application

-Clinical Assay- Market Size & Forecast 2018-2028F, USD Million

-Research & Development- Market Size & Forecast 2018-2028F, USD Million

By End User

-Hospitals- Market Size & Forecast 2018-2028F, USD Million

-Cancer Research Centers- Market Size & Forecast 2018-2028F, USD Million

-Specialty Cancer Clinics- Market Size & Forecast 2018-2028F, USD Million

-Clinical Laboratories- Market Size & Forecast 2018-2028F, USD Million

-Others (Contract Research Organizations (CROs), Contract Development & Manufacturing Organizations (CDMOs), etc.) - Market Size & Forecast 2018-2028F, USD Million

By Region

-North America

-South America

-Europe

-Middle East & Africa

-Asia-Pacific.

Note - If there are any particular details you need that are not currently included in the report, we will be happy to provide them as part of our customization services.

Top Companies Operating in the Global Immuno-Oncology Assay Market:

Agilent Technologies Inc., Aviva Systems Biology Corporation, PerkinElmer Inc., Bio-Rad Laboratories, Inc., Illumina Inc., Qiagen N.V, Thermo Fisher Scientific, Inc., Sartorius AG, NanoString Technologies, Inc., BioGenex, Abbott Laboratories, Inc., Asuragen Inc., Meso Scale Assay, LLC, Merck Millipore, Enzo Biochem Inc., and Others.

Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel, and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address

About Us –

We are a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.

Contact Us –

Email: sales@marknteladvisors.com

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511

Address Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India